Byers Capital
Menlo Park, Californiabyerscap.com
Overview
Byers Capital is a single family office that makes direct investments in technology and biotechnology companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Oryon Cell Therapies | Mar 2026 | Series A | Co-investor |
| Octave Bioscience | Sep 2025 | Series C | Co-investor |
| PinkDx | Jan 2025 | Series A Extension | Co-investor |
| ArsenalBio | Sep 2024 | Series C | Co-investor |
| PinkDx | Apr 2024 | Series A | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.